Siga Technologies Inc (SIGA)

Apr 8, 2025, 7:30 AM EDT - 18 days ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Apr 7, 2025, 3:02 AM EDT - 19 days ago

SIGA Technologies: Asymmetric Upside, If 2025 Goes Right

Mar 18, 2025, 7:30 AM EDT - 5 weeks ago

SIGA Appoints Retired General John M. Keane to its Board of Directors

Mar 11, 2025, 8:55 PM EDT - 6 weeks ago

SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 4:05 PM EDT - 6 weeks ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Mar 4, 2025, 7:30 AM EST - 7 weeks ago

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Jan 2, 2025, 7:30 AM EST - 4 months ago

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Dec 10, 2024, 4:00 PM EST - 4 months ago

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

Dec 2, 2024, 5:49 PM EST - 5 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

EBS

Nov 21, 2024, 5:01 PM EST - 5 months ago

SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket

Nov 8, 2024, 9:18 AM EST - 6 months ago

SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

Nov 7, 2024, 8:55 PM EST - 6 months ago

SIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 6 months ago

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Oct 23, 2024, 8:17 AM EDT - 6 months ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

Oct 22, 2024, 7:30 AM EDT - 6 months ago

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

Oct 8, 2024, 7:42 AM EDT - 7 months ago

Siga Technologies to supply mpox therapy in Morocco

Oct 8, 2024, 7:30 AM EDT - 7 months ago

SIGA Announces Agreement to Supply TPOXX® in Morocco

Oct 3, 2024, 12:00 PM EDT - 7 months ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Oct 2, 2024, 3:03 PM EDT - 7 months ago

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Sep 27, 2024, 8:22 AM EDT - 7 months ago

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws

Aug 21, 2024, 4:00 PM EDT - 8 months ago

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

Aug 16, 2024, 2:17 PM EDT - 9 months ago

Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

Aug 16, 2024, 8:00 AM EDT - 9 months ago

SIGA Technologies: Poised For A Potential Windfall From Monkeypox Emergency Declaration

Aug 15, 2024, 8:36 AM EDT - 9 months ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS GOVX

Aug 15, 2024, 7:35 AM EDT - 9 months ago

Topline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox Released

Aug 1, 2024, 9:57 PM EDT - 9 months ago

SIGA Technologies, Inc. (SIGA) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 7:30 AM EDT - 9 months ago

SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results

Jun 17, 2024, 4:05 PM EDT - 11 months ago

SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States

May 7, 2024, 9:02 PM EDT - 1 year ago

SIGA Technologies, Inc. (SIGA) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

SIGA Reports Financial Results for Three Months Ended March 31, 2024